ORIGINAL RESEARCH
Published on 22 Nov 2024
Analysis of factors influencing the efficacy of NAC and prognosis between HER2-zero and HER2-low HR negative breast cancer
doi 10.3389/fcell.2024.1417271
- 337 views
- Frontiers in Cell and Developmental Biology
- Cancer Cell Biology
- Research Topics
- Therapeutic Potential Affected by Tumor Microenvironment in Triple-Negative Breast Cancer
Therapeutic Potential Affected by Tumor Microenvironment in Triple-Negative Breast Cancer
2,295
Total downloads
8,936
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 04 Sep 2024
Evaluation of prognostic risk factors of triple-negative breast cancer with 18F-FDG PET/CT parameters, clinical pathological features and biochemical indicators
doi 10.3389/fcell.2024.1421981
- 772 views
ORIGINAL RESEARCH
Published on 02 Sep 2024
Development and validation of a nomogram for predicting rapid relapse in triple-negative breast cancer patients treated with neoadjuvant chemotherapy
doi 10.3389/fcell.2024.1417366
- 715 views
REVIEW
Published on 27 Feb 2024
Current progress and prospects for G protein-coupled estrogen receptor in triple-negative breast cancer
doi 10.3389/fcell.2024.1338448
- 2,249 views
- 2 citations
ORIGINAL RESEARCH
Published on 22 Feb 2024
Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study
doi 10.3389/fcell.2024.1313610
- 1,235 views
SYSTEMATIC REVIEW
Published on 09 Feb 2024
Addition of PD-1/PD-L1 inhibitors to chemotherapy for triple-negative breast cancer: a meta-analysis
doi 10.3389/fonc.2024.1309677
- 1,248 views
Published in
Frontiers in Cell and Developmental Biology
- Cancer Cell Biology
Impact
- 8,936Topic views
- 5,849Article views
- 2,295Article downloads